the tranSMART Foundation held a 2-day Launch Event, with talks and demonstrations held in the US and UK on successive days earlier this week. On Tuesday, September 9th, Brian Athey, CSO of the Foundation, hosted the Launch Event where attendees heard from CEO Keith Elliston on the achievement of the v1.2 Release. Keith echoed the sentiment of many, reflecting on the number of contributors and volunteer testers who helped bring the latest release to completion. Seven separate demonstrations were given of new features of the release, that is was highlighted by Brian as including core system improvements, interface changes, key new analysis features, new data types and the ability to connect to external services. A new look for the Foundation was also revealed in a new set of logos, a new website design as well as a number of other changes. The Event was wrapped up by Keith as he described the success of the past 18 months in achieving the goals set at that time. The next day, Yikes Guo, CTO of the Foundation, hosted a similar Event at the offices of IDBS in London. Again the demonstrations were very exciting in showing off the new version.
We will be adding content of interest to our Members and friends from not only Foundation activities but elsewhere from the field of translational medicine, genetic research, molecular medicine and related fields.
As part of our increased engagement with the scientific community, tranSMART has prepared and launched a YouTube channel that will allow access to recordings of past Annual Meetings (the 2013 Paris Meeting recordings are now available) as well as Monthly Community webinars and other informational audio and video components that will keep our international network up to date on tranSMART activities.
The tranSMART Foundation is charging forward with the continuing development of the tranSMART Version 1.2 platform, with our public Launch Events for the release on September 9th. Version 1.2 will see several additions and improvements, most notably support for both Oracle and Ingres. Additions include enhancements in cross trial analyses and in a built-out workspace that will allow for query settings to be saved between sets of analysis. Added to the feature set are Genome Wide Association Studies GWAS) as well as integration with R among several other key features.